The vaccine maker’s board intends to recommend a pending offer from investment firms Nordic Capital and Permira, which would take over the drugmaker and delist it from market.

A consortium led by Nordic Capital and Permira has made an around $3 billion offer to buy all shares in Bavarian Nordic, the vaccine maker said on Monday. Innosera, a newly formed company controlled ...

The directors of the vaccine maker said the offer from Permira and Nordic Capital was an attractive proposal and recommended that shareholders accept it.

COPENHAGEN, Denmark, July 31, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its ...

After what Bavarian Nordic described as “intense negotiations,” the Danish vaccine maker has agreed to be acquired by a private equity consortium in a 19 billion krone ($3 billion) deal.

Shares in Bavarian Nordic - one of the few drug firms with an mpox vaccine - were up about 19% since market close on Aug. 13, the day before the WHO announcement.

Employees of a Bavarian Nordic factory near Munich, Germany, are under pressure to produce more monkeypox vaccine doses as cases across the globe break 40,000, including a handful of deaths.

That’s how many vaccine doses Bavarian Nordic says it can supply by the end of 2025. Two million of these will be available over the remainder of 2024, the company said, a figure that includes ...

Bavarian Nordic’s stock soared 10% on Thursday after the Danish biotech company posted better-than-expected second-quarter earnings and unveiled an order for 440,000 doses of smallpox and mpox ...

Danish biotech firm Bavarian Nordic said on Tuesday it will donate 40,000 doses of its mpox vaccine to Africa's top public health body, after the body declared an emergency.

Bavarian Nordic is also in talks to potentially expand production capacity. Bavarian has annual production capacity of 30 million doses, including the monkeypox vaccine and other vaccines it makes.

Bavarian Nordic is talking to other manufacturers that could produce more doses, but that, too, generally takes at least four to six months, Mr. Chaplin said. A Bavarian Nordic laboratory near Munich.